Pneumonia in the very old

被引:321
作者
Janssens, JP
Krause, KH
机构
[1] Univ Hosp Geneva, Div Lung Dis, Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Geriatr, Geneva, Switzerland
关键词
D O I
10.1016/S1473-3099(04)00931-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pneumonia is a major medical problem in the very old. The increased frequency and severity of pneumonia in the elderly is largely explained by the ageing of organ systems (in particular the respiratory tract, immune system, and digestive tract) and the presence of comorbidities due to age-associated diseases. The most striking characteristic of pneumonia in the very old is its clinical presentation: falls and confusion are frequently encountered, while classic symptoms of pneumonia are often absent. Community-acquired pneumonia (CAP) and nursing-home acquired pneumonia (NHAP) have to be distinguished. Although there are no fundamental differences in pathophysiology and microbiology of the two entities, NHAP tends to be much more severe, because milder cases are not referred to the hospital, and residents of nursing homes often suffer from dementia, multiple comorbidities, and decreased functional status. The immune response decays with age, yet pneumococcal and influenza vaccines have their place for the prevention of pneumonia in the very old. Pneumonia in older individuals without terminal disease has to be distinguished from end-of-life pneumonia. In the latter setting, the attributable mortality of pneumonia is low and antibiotics have little effect on life expectancy and should be used only if they provide the best means to alleviate suffering. In this review, we focus on recent publications relative to CAP and NHAP in the very old, and discuss predisposing factors, microorganisms, diagnostic procedures, specific aspects of treatment, prevention, and ethical issues concerning end-of-life pneumonia.
引用
收藏
页码:112 / 124
页数:13
相关论文
共 161 条
[51]  
GYETKO MR, 1993, CLIN CHEST MED, V14, P379
[52]   Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults [J].
Hamel, MB ;
Davis, RB ;
Teno, JM ;
Knaus, WA ;
Lynn, J ;
Harrell, F ;
Galanos, AN ;
Wu, AW ;
Phillips, RS .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (10) :721-+
[53]   CLINICAL ASPECTS OF PNEUMONIA IN THE ELDERLY VETERAN [J].
HARPER, C ;
NEWTON, P .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (09) :867-872
[54]   Procalcitonin and C-reactive protein levels in community-acquired pneumonia: Correlation with etiology and prognosis [J].
Hedlund, J ;
Hansson, LO .
INFECTION, 2000, 28 (02) :68-73
[55]   Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella urinary antigen EIA [J].
Helbig, JH ;
Uldum, SA ;
Lück, PC ;
Harrison, TG .
JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (06) :509-516
[56]   The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia [J].
Ho, JC ;
Chan, KN ;
Hu, WH ;
Lam, WK ;
Zheng, L ;
Tipoe, GL ;
Sun, J ;
Leung, R ;
Tsang, KW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (04) :983-988
[57]   Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient [J].
Hogarth, MB ;
Gallimore, JR ;
Savage, P ;
Palmer, AJ ;
Starr, JM ;
Bulpitt, CJ ;
Pepys, MB .
AGE AND AGEING, 1997, 26 (02) :153-158
[58]   Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older [J].
Honkanen, PO ;
Keistinen, T ;
Miettinen, L ;
Herva, E ;
Sankilampi, U ;
Läärä, E ;
Leinonen, M ;
Kivelä, SL ;
Mäkela, PH .
VACCINE, 1999, 17 (20-21) :2493-2500
[59]  
HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177
[60]  
HORNER J, 1988, NEUROLOGY, V38, P1359